{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:19:46Z","timestamp":1792804786991,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.bioorg.2019.103438","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T11:29:43Z","timestamp":1573644583000},"page":"103438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: Design, synthesis, selective COX-2, DHFR and molecular-modeling study"],"prefix":"10.1016","volume":"99","author":[{"given":"Nadia Hanafy","family":"Metwally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Said","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103438_b0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2019.103438_b0010","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chin","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2019.103438_b0015","first-page":"67","article-title":"The role of humoral immunity and acute inflammation in protection against staphyloccocal dermonecrosis","volume":"29","author":"Easmon","year":"1975","journal-title":"Immunology"},{"key":"10.1016\/j.bioorg.2019.103438_b0020","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2217\/imt.11.113","article-title":"Chronic inflammation and immunologic-based constraints in malignant disease","volume":"3","author":"Lowe","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.bioorg.2019.103438_b0025","first-page":"1575","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bioorg.2019.103438_b0030","article-title":"Mechanisms of inflammation in neutrophil-mediated skin diseases","volume":"10","author":"Marzano","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2019.103438_b0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: quintiles prize lecture 2005","volume":"148","author":"Barnes","year":"2006","journal-title":"B. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103438_b0040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4155\/tde-2017-0055","article-title":"In situ delivery of corticosteroids for treatment of oral diseases","volume":"8","author":"Caro","year":"2017","journal-title":"Ther. Delivery"},{"key":"10.1016\/j.bioorg.2019.103438_b0045","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s13760-017-0772-0","article-title":"Corticosteroids in the management of acute multiple sclerosis exacerbations","volume":"117","author":"Smets","year":"2017","journal-title":"Act. Neurol. Belg."},{"key":"10.1016\/j.bioorg.2019.103438_b0050","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/ijms20061511","article-title":"Therapeutic targeting steroid resistant pro-inflammatory NK and NKT-like cells in chronic inflammatory lung disease","volume":"20","author":"Hodge","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2019.103438_b0055","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bioorg.2019.103438_b0060","first-page":"117","article-title":"New insight on inflammation and its management: a review","volume":"4","author":"Dhingra","year":"2017","journal-title":"J. Innovations Pharm. Biolog. Sci."},{"key":"10.1016\/j.bioorg.2019.103438_b0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.14336\/AD.2017.0306","article-title":"A Comprehensive review of non-steroidal anti-inflammatory drug use in the elderly","volume":"9","author":"Wongrakpanich","year":"2018","journal-title":"Aging Dis."},{"key":"10.1016\/j.bioorg.2019.103438_b0070","article-title":"Disease-modifying effects of long-term and continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) in spondyloarthritis","author":"Wong","year":"2019","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2019.103438_b0075","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2147\/TCRM.S82049","article-title":"Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: As-yet-unused weapons of the oncologists arsenal","volume":"11","author":"Papanagnou","year":"2015","journal-title":"Ther. and Clin. Risk Manag."},{"key":"10.1016\/j.bioorg.2019.103438_b0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semarthrit.2015.11.009","article-title":"Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys","volume":"45","author":"Pelletier","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.bioorg.2019.103438_b0085","first-page":"1","article-title":"Safety considerations for NSAIDs","volume":"24","author":"Aranguren","year":"2018","journal-title":"Drug Ther. Bull. Navarre Spain"},{"key":"10.1016\/j.bioorg.2019.103438_b0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1253\/circj.CJ-12-1573","article-title":"Assessing the cardiovascular risk between celecoxib and nonselective nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis and osteoarthritis","volume":"78","author":"Hirayama","year":"2014","journal-title":"Circulation J."},{"key":"10.1016\/j.bioorg.2019.103438_b0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0960-894X(01)00800-9","article-title":"Structure-based design of cyclooxygenase-2 selectivity into ketoprofen","volume":"12","author":"Palomer","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103438_b0100","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.2147\/JPR.S186000","article-title":"Safety of celecoxib versus traditional non-steroidal anti-inflammatory drugs in older patients with arthritis","volume":"11","author":"Shin","year":"2018","journal-title":"J. Pain Res."},{"key":"10.1016\/j.bioorg.2019.103438_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/medicines4030058","article-title":"Antimicrobial activity of some essential oils-present status and future perspectives","volume":"4","author":"Chouhan","year":"2017","journal-title":"Medicines"},{"key":"10.1016\/j.bioorg.2019.103438_b0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jor.23656","article-title":"Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopaedic infections","volume":"36","author":"Li","year":"2018","journal-title":"J. Orthop Res."},{"key":"10.1016\/j.bioorg.2019.103438_b0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.18869\/modares.iem.2.1.25","article-title":"Pseudomonas aeruginosa: A review of their pathogenesis and prevalence in clinical settings and the environment","volume":"2","author":"Streeter","year":"2016","journal-title":"Infect. Epidemiol. Med."},{"key":"10.1016\/j.bioorg.2019.103438_b0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/cai.cai_11_17","article-title":"An epidemiological study of health-care-associated infections and their antimicrobial sensitivity pattern in the Al-Qassim region of Kingdom of Saudi Arabia","volume":"4","author":"Gupta","year":"2017","journal-title":"Commun. Acqu. Infect."},{"key":"10.1016\/j.bioorg.2019.103438_b0125","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2147\/IDR.S174940","article-title":"Molecular epidemiology of pseudomonas aeruginosa in university clinical center of Kosovo","volume":"11","author":"Lila","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.bioorg.2019.103438_b0130","first-page":"1","article-title":"Risk factors for hospitalized patients with resistant or multidrug-resistant pseudomonas aeruginosa infections: A systematic review and meta-analysis","volume":"7","author":"Raman","year":"2018","journal-title":"Antimicrob. Resist. Infect. Cont."},{"key":"10.1016\/j.bioorg.2019.103438_b0135","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1462-2920.2011.02469.x","article-title":"The pseudomonas aeruginosa opportunistic pathogen and human infections","volume":"13","author":"Bentzmann","year":"2011","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.bioorg.2019.103438_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins10060252","article-title":"Staphylococcus aureus. Toxins and their molecular activity in infectious diseases","volume":"10","author":"Oliveira","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bioorg.2019.103438_b0145","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/nu2030290","article-title":"Streptococcus mutans, caries and simulation models","volume":"2","author":"Forssten","year":"2010","journal-title":"Nutrients"},{"key":"10.1016\/j.bioorg.2019.103438_b0150","first-page":"594","article-title":"Novel imidazole congeners as anti-inflammatory agent","volume":"69","author":"Bhalla","year":"1992","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103438_b0155","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.3390\/molecules171012262","article-title":"Design, synthesis and in vivo anti-inflammatory activities of 2,4-diaryl-5-4H-imidazolone derivatives","volume":"17","author":"El-Araby","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103438_b0160","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cclet.2016.01.049","article-title":"Synthesis, antimicrobial and anti-inflammatory activities of some novel 5-substituted imidazolone analogs","volume":"27","author":"Dhingra","year":"2016","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103438_b0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bioorg.2017.04.002","article-title":"New 1,2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents","volume":"72","author":"Abdellatif","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103438_b0170","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.3390\/molecules171012262","article-title":"Design, synthesis and in vivo anti-inflammatory activities of 2,4-diaryl-5-4H-imidazolone derivatives","volume":"17","author":"El-Araby","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103438_b0175","doi-asserted-by":"crossref","first-page":"562","DOI":"10.5012\/bkcs.2014.35.2.562","article-title":"Synthesis, characterization and antimicrobial activity of novel pharmacophores incorporating imidazoline-oxazoline Scaffold","volume":"35","author":"Barakat","year":"2014","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103438_b0180","first-page":"51","article-title":"Synthesis of 5-oxo-imidazolines derivatives as anti-microbial agents","volume":"4","author":"Chatrabhuji","year":"2015","journal-title":"Int. J. Chemtech. Appl."},{"key":"10.1016\/j.bioorg.2019.103438_b0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.arabjc.2012.10.020","article-title":"A new synthetic approach and in vitro antimicrobial evaluation of novel imidazole incorporated 4-thiazolidinone motifs","volume":"10","author":"Desai","year":"2017","journal-title":"Arab. J Chem."},{"key":"10.1016\/j.bioorg.2019.103438_b0190","first-page":"1090","article-title":"Synthesis and antibacterial screening of 4-arylidene5-oxo-imidazoles having carboxamide linkage with 5-(benzofuran-2-yl)-1-phenylpyrazole moiety","volume":"5","author":"Idrees","year":"2016","journal-title":"Chem. Sci. Trans."},{"key":"10.1016\/j.bioorg.2019.103438_b0195","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1007\/s00044-012-9983-3","article-title":"Synthesis and anticonvulsant activity of novel imidazol5(4H) one and 5-oxo-4,5-dihydroimidazol-1-yl)propanamide derivatives","volume":"21","author":"Kalifa","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.103438_b0200","first-page":"107","article-title":"Synthesis and antimicrobial activity of 2-{[(4\u2019-arylidine-5\u2019oxo-2\u2019 phenyl) imidazolyl]-1\u2019-yl}-3-keto-1,5-dimethyl-2-phenyl pyrazole","volume":"8","author":"Vagadiya","year":"2019","journal-title":"J. Appl. Chem."},{"key":"10.1016\/j.bioorg.2019.103438_b0205","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2174\/1570180054771554","article-title":"Immunomodulatory properties of synthetic imidazolone derivatives","volume":"2","author":"Mesaik","year":"2005","journal-title":"Lett. Drug Design Discov."},{"key":"10.1016\/j.bioorg.2019.103438_b0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/157018009787158553","article-title":"Synthesis and antibacterial and antifungal activity of 5-substituted imidazolones","volume":"6","author":"Khan","year":"2009","journal-title":"Lett. Drug Desgn Discov."},{"key":"10.1016\/j.bioorg.2019.103438_b0215","first-page":"1","article-title":"1,2,4-Oxadiazole\/2-imidazoline hybrids: Multi-target-directed compounds for the treatment of infectious diseases and cancer","volume":"20","author":"Shtnev","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2019.103438_b0220","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1248\/cpb.c14-00885","article-title":"Synthesis and anticancer activity of some new thiopyrano[2,3-d]thiazoles incorporating pyrazole moiety","volume":"63","author":"Metwally","year":"2015","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2019.103438_b0225","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s11164-015-2074-6","article-title":"Synthesis and anticancer activity of some new heterocyclic compounds based on 1-cyanoacetyl-3,5-dimethylpyrazole","volume":"42","author":"Metwally","year":"2016","journal-title":"Res. Chem. Inter."},{"key":"10.1016\/j.bioorg.2019.103438_b0230","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1002\/jhet.3290","article-title":"Synthesis, molecular docking, and biological evaluation of some novel bis-heterocyclic compounds based N, N\u2032-([1,1\u2032-biphenyl]-4,4\u2032-diyl)bis(2-cyanoacetamide) as potential anticancer agents","volume":"55","author":"Metwally","year":"2018","journal-title":"J. Heterocycl Chem."},{"key":"10.1016\/j.bioorg.2019.103438_b0235","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bioorg.2017.12.032","article-title":"Synthesis, anticancer assessment on human breast, liver and colon carcinoma cell lines and molecular modeling study using novel pyrazolo[4,3-c]pyridine derivatives","volume":"77","author":"Metwally","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103438_b0240","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1080\/00397911.2018.1495234","article-title":"Green synthesis of some new thiopyrano[2,3-d][1,3]thiazoles using lemon juice and their antibacterial activity","volume":"48","author":"Metwally","year":"2018","journal-title":"Synth. Comm."},{"key":"10.1016\/j.bioorg.2019.103438_b0245","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bioorg.2018.11.050","article-title":"Design, synthesis, DNA assessment and molecular docking study of novel 2-(pyridin-2-ylimino)thiazolidin-4-one derivatives as potent antifungal agents","volume":"84","author":"Metwally","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103438_b0250","doi-asserted-by":"crossref","first-page":"102929","DOI":"10.1016\/j.bioorg.2019.102929","article-title":"Design, synthesis, anticancer evaluation, molecular docking and cell cycle analysis of 3-methyl-4,7-dihydropyrazolo[1,5-a]pyrimidine derivatives as potent histone lysine demethylases (KDM) inhibitors and apoptosis inducers","volume":"88","author":"Metwally","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103438_b0255","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bioorg.2019.103438_b0260","unstructured":"A.C. Scott, \u201cLaboratory control of antimicrobial therapy,\u201d in: J.G. Collee, J.P. Duguid, A.G. Fraser, B.P. Marmion, (Eds.), Mackie and MacCartney Practical Medical Microbiology, 2, 161-181, Churchill Livingstone, Edinburgh, Scotland, 13th edition, 1989."},{"key":"10.1016\/j.bioorg.2019.103438_b0265","first-page":"541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.bioorg.2019.103438_b0270","first-page":"5023","article-title":"Design, synthesis and biological evaluation of glycogen synthesis kinase-3\u03b2 inhibitors as antidiabetic agents","volume":"5","author":"Jain","year":"2014","journal-title":"Int. J. Pharam. Sci. Res."},{"key":"10.1016\/j.bioorg.2019.103438_b0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/molecules13010011","article-title":"Design and synthesis of novel N-benzylidenrsulfonohydrazide inhibitors of MurC and MurD as potential antibacterial agents","volume":"13","author":"Frlan","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103438_b0280","first-page":"302","article-title":"CyclooXgenase. Methods and protocols. Springer protocols. Molecular biology 664","volume":"71","author":"Ayoub","year":"2010","journal-title":"B J. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103438_b0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nature Protocols"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819310090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819310090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:09:47Z","timestamp":1758614987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819310090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":57,"alternative-id":["S0045206819310090"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103438","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: Design, synthesis, selective COX-2, DHFR and molecular-modeling study","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103438"}}